サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：心臓カテーテルおよびガイドワイヤーの世界市場-2023年～2030年
市場調査レポート
商品コード
1316238

心臓カテーテルおよびガイドワイヤーの世界市場-2023年～2030年

Global Cardiac Catheters and Guidewires Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心臓カテーテルおよびガイドワイヤーの世界市場-2023年～2030年
出版日: 2023年07月27日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の心臓カテーテルおよびガイドワイヤー市場は、2022年に136億米ドルに達し、2030年には243億米ドルに達するなど、有利な成長が予測されています。世界の心臓カテーテルおよびガイドワイヤー市場は、予測期間中（2023-2030年）に7.7%のCAGRを示すと予測されています。

心臓カテーテルおよびガイドワイヤー市場には、特定の診断または介入処置用に設計されたさまざまなタイプのカテーテルが含まれます。これには、血管造影カテーテル、バルーンカテーテル、電気生理学カテーテル、血管内超音波（IVUS）カテーテルなどが含まれます。各タイプのカテーテルは、心血管疾患の診断、アクセス、治療において独自の目的を果たします。

世界の心臓カテーテル市場は、心血管疾患の有病率の増加、技術の進歩、低侵襲手技への移行などの要因により、着実な成長を遂げています。同市場は、心血管疾患の正確な診断と効果的な治療に対する需要の高まりにより、今後も成長軌道を維持すると予想されます。

市場力学

低侵襲手技の増加がカテーテルおよびガイドワイヤー市場の成長を牽引

Biomed Centralによると、2022年9月、Minimally-invasive cardiac surgery（低侵襲心臓手術）と名付けられた論文は、症例がより複雑になるにつれて、低侵襲手技がより顕著になり始めたと述べている高度なトレーニングを促進する鍵となるものを特定するために、影響と力の書誌学的分析を実施しました。1990年代半ばの時点で、ミニ胸骨切開術やミニ胸腔切開術を含む手技が開発されています。

継続的な研究開発により、MICSは心臓胸部外科の研修において非常に広く普及するようになり、主要な研究分野を特定することは、将来の研修や研究の指針となるであろう。

好意的な償還政策が心臓カテーテルおよびガイドワイヤー市場の成長を後押し

償還政策は、特定の心臓カテーテル治療に対してヘルスケアプロバイダーに提供される償還額を規定します。これらの方針は、手技の複雑さ、使用されるカテーテルの種類、手技中に利用される関連ヘルスケアリソースなどの要因を考慮することが多いです。診療報酬政策は、心臓カテーテル治療を実施するために医療提供者に提供される保険や金銭的報酬のレベルを決定するため、心臓カテーテル市場において重要な役割を果たしています。

例えば、Shockwave Medical社によると、2021年初頭にCoronary IVLを発売して以来、2022年7月1日、Shockwave社は償還に関して深く大きく前進しました。彼らは外来、ASC、入院患者での償還を獲得しています。

心臓カテーテル治療における高い合併症リスクが市場の成長を妨げる

心臓カテーテル治療では血管にカテーテルを挿入するため、血管に損傷を与える可能性があります。これには血管穿孔、解離（血管壁の断裂）、破裂などが含まれます。血管の損傷は出血や血腫形成を引き起こしたり、外科的修復を必要とすることもあります。血栓形成はカテーテル内またはその周囲で起こり、合併症を引き起こす可能性があります。血栓症は血流を阻害し、患部の虚血や梗塞を引き起こす可能性があります。血栓症を予防するために、術前、術中、術後に抗凝固薬や抗血小板薬が投与されることがあります。

2023年4月14日付のCardioVascular Groupによると、心臓カテーテル検査に伴う最も一般的なリスクは出血です。手技の間、カテーテルを挿入するために小さな切開が行われるが、これが出血につながることがあります。時には、挿入部位の周囲に血腫（血液の集まり）ができることもあります。これは痛みを伴い、さらなる治療が必要になることもあります。

心臓カテーテル治療のもう一つのリスクは感染です。この手技は血流に触れるため、感染のリスクがあります。不整脈と呼ばれる心調律異常は、心臓カテーテル検査中や検査後に起こることがあります。不整脈は、手技中の血流の変化や、カテーテルが心筋とこすれることによって生じることがあります。不整脈の大部分は小さく、自然に治りますが、時には危険な場合もあり、医師の診察が必要です。

COVID-19影響分析

COVID-19の流行は世界の心臓カテーテルおよびガイドワイヤー市場に大きな影響を与えました。心臓カテーテルやガイドワイヤを含む医療機器の世界のサプライチェーンは、施錠、渡航制限、製造や流通の途絶などにより混乱しています。このため、特定の医療機器の入手性に課題が生じ、製品供給が変動しています。

パンデミックの間、患者は定期的な検診やスクリーニングを延期した可能性があり、その結果、通常は心臓カテーテル治療を必要とする心血管系の疾患の発見や診断が減少しました。このような患者の受診や検診の減少は、心臓カテーテルやガイドワイヤーの使用率に影響を与えています。

ロシア・ウクライナ紛争分析

紛争によってロシアとウクライナの間には地政学的緊張、国境紛争、貿易の混乱が生じています。こうした混乱は心臓カテーテルを含む医療機器のサプライチェーンに影響を及ぼす可能性があります。これらの医療機器の輸出入に制限や遅延が生じれば、供給不足や供給遅延につながり、市場に影響を及ぼす可能性があります。

紛争が続いているため、ロシアとウクライナの両国で経済が不安定になっています。景気後退や通貨変動は、医療機器市場を含むヘルスケア分野に波及する可能性があります。ヘルスケアシステム内での購買力の低下や予算の制約が、心臓カテーテルやガイドワイヤーの需要や調達に影響を与える可能性があります。

紛争時には、ヘルスケアの優先順位が、戦争による負傷の治療を含む救急医療や外傷治療にシフトすることが多いです。このような焦点の変化により、心臓カテーテル器具を必要とするような非緊急医療処置に重点が置かれなくなる可能性があります。リソースがより緊急性の高いヘルスケア・ニーズに振り向けられることで、そのような機器に対する全体的な需要が影響を受ける可能性があります。したがって、上記の要因を考慮すると、世界の心臓カテーテルおよびガイドワイヤー市場は、ロシアとウクライナの紛争によって中程度の影響を受けています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • カテーテルおよびガイドワイヤーにおける技術の進歩
      • 心臓カテーテルおよびガイドワイヤーに関する臨床試験の増加
    • 抑制要因
      • 外科手術と心臓カテーテルの高コスト
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • アンメットニーズ
  • 規制分析

第6章 COVID-19分析

第7章 ロシア・ウクライナ戦争分析

第8章 製品タイプ別

  • 心臓カテーテル
  • 心臓ガイドワイヤー

第9章 用途別

  • バルーンセプトストミー
  • 冠動脈形成術
  • カテーテルアブレーション
  • 左/右心カテーテル治療

第10章 エンドユーザー別

  • 病院
  • 診療所
  • 外来手術センター

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市場シェア分析
  • M&A分析

第13章 企業プロファイル

  • Abbott Healthcare Pvt. Ltd
    • 製品ポートフォリオと概要
    • 財務概要
  • Boston Scientific Corp
  • Biotronik
  • Medtronic
  • Terumo Medical Corporation
  • Cordis
  • Teleflex Inc
  • Nipro
  • BrosMed Medical Co
  • Merit Medical Sysytem

第14章 付録

目次
Product Code: MD6508

Market Overview

The global cardiac catheters and guidewires market reached US$ 13.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 24.3 billion by 2030. The global cardiac catheters and guidewires market is expected to exhibit a CAGR of 7.7% during the forecast period (2023-2030).

The cardiac catheter and guidewire market encompass various types of catheters designed for specific diagnostic or interventional procedures. These include angiography catheters, balloon catheters, electrophysiology catheters, and intravascular ultrasound (IVUS) catheters, among others. Each type of catheter serves a unique purpose in diagnosing, accessing, or treating cardiovascular conditions.

The global cardiac catheter market is witnessing steady growth due to factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the shift toward minimally invasive procedures. The market is expected to continue its growth trajectory in the coming years, driven by the rising demand for accurate diagnosis and effective treatment of cardiovascular conditions.

Market Dynamics

Increasing Minimally Invasive Procedures Drives the Growth of Catheter and Guidewire Market

According to Biomed Central, in September 2022, an article named Minimally-invasive cardiac surgery conducted a bibliometric analysis of impact and force to identify key and facilitating advanced training which states that minimally-invasive techniques have started to become more prominent as cases become more complex. As of the mid-1990s there are been development of techniques to involve mini-sternotomy and mini-thoracotomy approaches.

With continued research and development, MICS is set to become highly prevalent in Cardiothoracic Surgery training and identifying key areas of research would help to guide training and research in the future.

Favorable Reimbursement Policies are Boosting the Cardiac Catheters and Guidewires Market Growth

Reimbursement policies define the amount of reimbursement provided to healthcare providers for specific cardiac catheterization procedures. These policies often consider factors such as the complexity of the procedure, the type of catheter used, and the associated healthcare resources utilized during the procedure. Reimbursement policies play a crucial role in the cardiac catheter market as they determine the level of coverage and financial reimbursement provided to healthcare providers for performing cardiac catheterization procedures.

For instance, according to Shockwave Medical for instance, on July 1 2022, since the launch of Coronary IVL in early 2021, Shockwave has made deep and significant progress on reimbursement. They have reimbursement in the outpatient, ASC, and inpatient setting.

High Risk of Complications for Cardiac Catheterization Will Hamper the Growth of the Market

Cardiac catheterization involves the insertion of a catheter into blood vessels, which can potentially cause vessel damage. This can include vessel perforation, dissection (tearing of the vessel wall), or rupture. Vessel damage can result in bleeding, hematoma formation, or even require surgical repair. Blood clot formation can occur within or around the catheter, leading to potential complications. Thrombosis can obstruct blood flow, resulting in ischemia or infarction in the affected area. To prevent thrombosis, anticoagulant medications or antiplatelet agents may be administered before, during, or after the procedure.

According to CardioVascular Group, April 14 2023, the most common risks associated with cardiac catheterization is bleeding. During the procedure, a small incision is made to insert the catheter, and this can lead to bleeding. Sometimes, a hematoma, or a collection of blood, can form around the insertion site. This can be painful and may require further treatment.

Another risk of cardiac catheterization is of infection. Since the procedure involves accessing the bloodstream, there is a risk of infection. Heart rhythm abnormalities called arrhythmias can happen during or after cardiac catheterization. These may result from changes in blood flow during the procedure or from the catheter rubbing against the heart muscle. The majority of arrhythmias are small and go away on their own, but they can occasionally be dangerous and need medical attention.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global cardiac catheters and guidewire market. The global supply chains for medical devices, including cardiac catheters and guidewires have been disrupted due to lockdowns, travel restrictions, and disruptions in manufacturing and distribution. This has led to challenges in the availability of certain medical devices and fluctuations in product supply.

During the pandemic, patients may have postponed regular check-ups and screenings, resulting in decreased detection and diagnosis of cardiovascular conditions that would typically require cardiac catheterization procedures. This decline in patient visits and screenings has impacted the utilization of cardiac catheters and guidewires.

Russia-Ukraine Conflict Analysis

The conflict has created geopolitical tensions, border disputes, and trade disruptions between Russia and Ukraine. These disruptions can potentially affect the supply chain of medical devices, including cardiac catheter devices. If there are restrictions or delays in the import/export of these devices, it could lead to shortages or delays in their availability, impacting the market.

The ongoing conflict has resulted in economic instability in both Russia and Ukraine. Economic downturns and currency fluctuations can have a ripple effect on the healthcare sector, including medical device markets. Reduced purchasing power and budgetary constraints within healthcare systems may impact the demand and procurement of cardiac catheters and guidewires.

During times of conflict, healthcare priorities often shift towards emergency and trauma care, including the treatment of war-related injuries. This shift in focus may result in a reduced emphasis on non-emergency medical procedures, including those requiring cardiac catheter devices. The overall demand for such devices could be impacted as resources are redirected towards more urgent healthcare needs. Therefore, considering the above factors, the global cardiac catheters and guidewires market has been moderately affected by the conflict between Russia and Ukraine.

Segment Analysis

The cardiac catheters and guidewires market is segmented based on product type, application, end-user, and geography.

Owing to the Increasing Prevalence of Cardiovascular Disease, Rising Clinical Trials, the Hospital Segment Accounted for Approximately 45.5% of the Cardiac Catheters and Guidewires Market Share

Hospitals are the primary users of cardiac catheters and guidewires as these devices are essential for performing various cardiovascular procedures. Hospitals generate demand for these devices based on their patient population and the prevalence of cardiovascular diseases in their region. Hospitals are responsible for the procurement and purchasing of cardiac catheters and guidewires. They establish contracts with medical device manufacturers and suppliers to ensure a steady supply of these devices for their cardiovascular departments.

For instance, on April 25 2022, New York-Presbyterian Hudson Valley Hospital launched Interventional Cardiology program and opens state-of-the-art cardiac catheterization lab. It is designed to support cardiac health and bring world-class interventional cardiology care to the Hudson Valley and upper Westchester region. The interventional cardiology program provides a variety of emergent procedures, including cardiac angioplasty to improve blood flow in narrow or blocked arteries for patients experiencing a heart attack or chest pain. Advanced cardiac services include diagnostic cardiac catheterization (a procedure in which a catheter is guided through a blood vessel in the heart to diagnose certain heart conditions) and minimally invasive procedures to open clogged arteries.

Geographical Analysis

North America Accounted for Approximately 39.4% of the Market Share in 2022, Owing to the Increasing Research and Development Activities and Well-Established Healthcare Infrastructure

North America plays a significant role in the cardiac catheter and guidewire market and is a major contributor to its growth. North America, particularly the United States, has a well-developed and advanced healthcare infrastructure. The region is known for its state-of-the-art medical facilities, highly skilled healthcare professionals, and advanced technologies.

This infrastructure supports the adoption and utilization of cardiac catheters in various cardiovascular procedures. It also has a high prevalence of cardiovascular diseases, including coronary artery disease, hypertension, and heart failure. These conditions often require diagnostic and interventional procedures, such as cardiac catheterization, to assess and treat the cardiovascular system. The increasing incidence of these diseases drives the demand for cardiac catheters in the region.

North America is home to several leading medical device manufacturers and market players in the cardiac catheter segment. These companies invest in research and development activities to introduce innovative catheter technologies, enhance procedural outcomes, and improve patient safety. The presence of these established market players further stimulates market growth.

For instance, on Feb 2, 2022. as part of its expanding line of electrophysiological products for the international market, Abbott announced two approvals. The business's TactiFlex Ablation Catheter, Sensor Enabled, the only ablation catheter in the world with a flexible tip and contact force sensing, has been granted CE Mark 1 for the purpose of treating patients with unnatural heart rhythms such atrial fibrillation (AFib). The U.S. Food and Drug Administration (FDA) recently granted an additional indication for using Abbott's FlexAbility Ablation Catheter, Sensor Enabled to treat patients with complicated cardiac conditions.

Competitive Landscape

The major global players in the market include: Abbott Healthcare Pvt. Ltd., Boston Scientific Corp, Biotronic, Medtronic, Terumo Medical Corporation Access, Cordis, Teleflex Inc., Nipro, BrosMed Medical co., Merit Medical System among others

Why Purchase the Report?

  • To visualize the cardiac catheters and guidewires market segmentation based on the product type, by application, by end-user and by region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of cardiac catheters and guidewires market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global cardiac catheters and guidewires market report would provide approximately 69 tables, 70 figures, and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Geography

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technology Advancements in Catheter and Guidewires
      • 4.1.1.2. Increasing Number of Clinical Trials on Cardiac Catheters and Guidewires
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Surgical Procedures and Cardiac Catheters
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario before COVID-19
    • 6.1.2. Scenario during COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Product type

  • 8.1. Introduction
  • 8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.3. Market Attractiveness Index, By Product Type
  • 8.4. Cardiac Catheters
  • 8.5. Introduction
  • 8.6. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.7. Cardiac Guidewires

9. By Application

  • 9.1. Introduction
  • 9.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3. Market Attractiveness Index, By Application
  • 9.4. Balloon Septostomy
  • 9.5. Introduction
  • 9.6. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.7. Coronary Angioplasty
  • 9.8. Catheter Ablation
  • 9.9. Left/Right Heart Catheterization

10. By End Users

  • 10.1. Introduction
  • 10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  • 10.3. Market Attractiveness Index, By End Users
  • 10.4. Hospitals
  • 10.5. Clinics
  • 10.6. Ambulatory Surgery Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Geography
      • 11.2.6.1. U.S.
      • 11.2.6.2. Canada
      • 11.2.6.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Geography
      • 11.3.6.1. Germany
      • 11.3.6.2. U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Italy
      • 11.3.6.5. Spain
      • 11.3.6.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Geography
      • 11.4.5.1. Brazil
      • 11.4.5.2. Argentina
      • 11.4.5.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.5.1. China
      • 11.5.5.2. India
      • 11.5.5.3. Japan
      • 11.5.5.4. Australia
      • 11.5.5.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Abbott Healthcare Pvt. Ltd
    • 13.1.1. Product Portfolio and Description
    • 13.1.2. Financial Overview
  • 13.2. Boston Scientific Corp
  • 13.3. Biotronik
  • 13.4. Medtronic
  • 13.5. Terumo Medical Corporation
  • 13.6. Cordis
  • 13.7. Teleflex Inc
  • 13.8. Nipro
  • 13.9. BrosMed Medical Co
  • 13.10. Merit Medical Sysytem

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us